Photodynamic therapy for gastrointestinal tumors using three photosensitizers-ALA induced PPIX, photofrin® and MTPHC. A pilot study

Neoplasma

Volumn 45, Issue 3, 1998, Pages 157-161

  Mlkvy, P ^a   Messmann, H ^b   Regula, J ^c   Conio, M ^d   Pauer, M ^e   Millson, C E ^e   MacRobert, A J ^e   Bown, S G ^e  

^a St Elisabeth' Oncological Institute   (Slovakia)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Department of Gastroenterology   (Poland)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Endoscopic therapy; Gastrointestinal tumors; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; MESOTETRAHYDROXYPHENYLCHLORIN; PHOTOFRIN; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; TREATMENT OUTCOME;

EID: 0031814833     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. ABULAFI, A.M., ALLARDICE, J.T., WILLIAMS, N.S., VAN SOMEREN, N., SWAIN, C.P., AINLEY, C.A.: Photodynamic therapy for malignant tumors of the Ampulla of Vater.GUT, 36, 1995, 853-856.
2. BARR, H., KRASNER, N., BOULOUS, P.B., CHATLANI, P., BOWN, S.G.: Photodynamic therapy for colorectal cancer: A quantitative pilot study. Br. J. Surg., 77, 1990, 93-98.
3. BEDWELL, J., MACROBERT, A.J., PHILLIPS, D., BOWN, S.O.: Fluorescence distribution and photodynamic effect of ALA-induced PPIX in DMH rat colonic tumor model. Br. J. Cancer, 65, 1992, 818-824.
4. BERENBAUM, M.C., BONNET, R., CHEVRETTON, E.B., AKANDE-EBAKIN, S.L., RUSTOOM, M.: Selectivity of meso Tetra(hydroxyphenyl) porphyrins and chlorins and of Photofrin II,causing photodamage in tumors,skin muscle and bladder. The concept of cost and benefit analysis results. Lasers Med. Sci., 8, 1993, 235-237.
5. BERLIN, N.I., NEUBERGER, A., SCOTT, J.J.: The metabolism of 5 aminolaevulmic acid.1 Normal pathways, studied with the aid of 15 N. Biochem. J., 64, 1956, 80-87.
6. BONNET, R., IOANNOUS, S., WINFIELD, U.J., BERENBAUM, M.C.: meso(Tetra(hydroxyphenyl) porphyrins as tumor photosensitisers: Chemical and photochemical aspects. Photochem. Photobiol., Suppl., 45, 1987.
7. BONNET, R., WHITE, R.D., WINFIELD, U.J., BERENBAUM, M.C.: Hydroporhyrins of the meso-tetra(hydroxyphenyl)porphyrins series as a tumor photosensitisers. Biochem, J., 261, 1989, 277-281.
8. CHAN, W.S., MACROBERT, A.J., PHILLIPS, D., HART, I.R.: Use of charged couple device for imaging of intracellular phtalocyanines. Photochem. Photobiol., 50, 1989, 617-621.
9. CHEVRETTON, E.B., BERENBAUM, M.C., BONNET, R.: The effect of photodynamic therapy on normal skelet muscle in animal model. Lasers Med. Sci., 7, 1992, 103-105.
10. DOUGHERTY, T.J., COOPER, M.T., MANG, T.S.: Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Surg. Med., 10, 1990, 485-491.
11. DOUGHERTY, T.J., POTTER, W.R., WEISHAUPT, K.R.: The structure of active component of hematoporphyrin derivate. In: Porphyrinium Localization and Treatment of Tumors. Eds: Dioron, D.R., Gomer, C.J. New York, Alan R. Liss 1984, 301-387.
12. EVENSEN, J.F, SOMMER, S., MOAN, J., CHRISTONSEN, T.: Tumor localising and photosensitising properties of the main components of hematoporphyrin derivate. Cancer Res., 44, 1984, 482-489.
13. GRAHAME SMITH, D.G., ARONSON, J.K.: Oxford Textbook of Clinical Pharmacology and Drug Therapy. Oxford, Oxford University Press 1992, 13-17.
14. GRANT, W.E., HOPPPER, C., MACROBERT, A.J., SPEIGHT, P.M., BOWN, S.G.: Photodynamic therapy of oral cancer: Photosensitisation with systemic aminolaevulinic acid. Lancet, 342, 1993, 147-151.
15. HENDERSON, B.W., WALDOW, S.M., MANG, T.S., POTTER, W.R., DOUOHERTY, T.J.: Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following PDT. Cancer Res., 45, 1985, 572-579.
16. KENNEDY, J.C., POTTIER, R.H.: Endogenous protoporphyrin IX, a clinically useful photosensitiser for photodynamic therapy. J. Photochem. Photobiol., 14, 1992, 275-279.
17. LOH, C.S., BLISS, P., BOWN, S.G., KRASNER, N.: Photodynamic therapy for villous adenoma of the colon and rectum. Endoscopy, 26, 1994, 243-246.
18. LOH, C.S., MACROBERT, A.J., BEDWELL, J., REGULA, J., KRASNER, N., BOWN, S.G.: Oral versus intravenous administration of 5 aminolaevulinic acid for photodynamic therapy. Br. J. Cancer, 68, 1993, 41-48.
19. MALIK, Z., LUGACI, H.: Destruction of erytroleukemic cells by photoactivation of endogenous porphyrins. Br. J. Cancer, 56, 1987, 589-593.
20. MLKVY, P., MESSMANN, H., STEWART, J.C.M., PAUER, M., MILLSON, C.E., MACROBERT, A.J., BOWN, S.G.: Distribution and photodynamic effect of mesotetrahydroxyphenylchlorin (mTHPc) in the pancreas and adjacent tissues in Syrian Golden Hamsters. Br. J. Cancer, 72, 1995, 59-64.
21. MLKVY, P., MESSMANN, H., DEBINSKI, H., REGULA, J., CONIO, M., SPIGELMANN, A., PHILLIPS, R., BOWN, S.G.: Photodynamic therapy in polyps in familial adenomatous polyposis. Eur. J. Cancer, 31A, 1995, 1160-1165.
22. MLKVY, P., MESSMANN, H., MACROBERT, A.J., PAUER, M., SAMS, V., DAVIES, C., STEWART, J.C.M., BOWM, S.G.: Photodynamic therapy of transplanted pancreatic cancer model using mesotetrahydroxyphenylchlorin (m-THPc). Br. J. Cancer, 76 (6), 1997, 713-718.
23. MUSTAJOKI, P., TIMONEN, K., GORCHEIN, A., SEPPALAINEN, A., MATIKAINEN, E., TENHUNEN, J.: Sustained high plasma 5 aminolaevulinic acid concentration in a volunteer: No porphyric symptoms. Eur. J. Clin. Invest., 22, 1992, 407-412.
24. OVERHOLT, B., PANJEHPOUR, M., TEFTELLAR, E., ROSE, M.: Photodynamic therapy of early adenocarcinoma in Barrett's esophagus. Gastrointest. Endoscopy, 39, 1993, 73-79.
25. PATRICE, T., FOULTIER, M.T., YACTAO, S., DOUET, M.C., MALOISEL, F., LE-BODIC, L.: Endoscopic photodynamic therapy with hematoporphyrin derivate in gastroenterology. J. Photochem. Photobiol., 6, 1990, 165-171.
26. PENG, Q., MOAN, J., WARLOE, T., NESLAND, J.M., RIMINGTON, C.: Distribution and photosensitising efficiency of porphyrins induced by application of exogenous 5-aminolaevulinic acid in mice bearing mammary carcinoma. Int. J. Cancer, 52, 1992, 433-439.
27. REGULA, J., MACROBERT, A.J., GORCHEIN, A., BUONACCORSI, G., SPENCER, G.M., BOWN, S.G.: Photosensitisation and photodynamic therapy of esophageal, duodenal and colorectal tumors using 5 aminolaevulinic acid induced protoporphyrin IX - a pilot study. GUT, 36, 1995, 67-72.
28. Ris, H.B., ATTERMATT, H.J., INDERBITSI, R., HESS, R.: Photodynamic therapy with chlorins for diffuse malignant mesothelioma: Initial clinical results. Br. J. Cancer, 64, 1991, 1116-1122.
29. SAVARY, J.F., MONNIER, P.H., FONTOLLIET, C., MIZERET, J., WAGNIERE, G., VAN DEN BERGH, H.: First clinical results after photodynamic treatment of early squamous cell carcinomas of the esophagus, bronchi and mouth with meso-tetrahydroxyphenylchlorin (m-THPc). Book of Abstracts International Photodynamic Meeting, Florida 1994, 51.
30. SCHRODER, T., CHEN, I.W., SPERLING, M., BELL, R.H., BRACKETT, K., JOFFE, S.N.: Haematoporphyrin uptake and photodynamic therapy in pancreatic carcinoma. J. Surg. Oncol., 38, 1988, 4-10.